Hologic is set for acquisition by Blackstone and TPG for up to $18.3bn in enterprise value, as part of a definitive agreement ...

Boston Scientific has lifted its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid continued ...

Hyperfine has enrolled the first subjects in the PRISM PMR trial, which aims to assess the application of the Swoop portable ...

Demand for gender-specific medical innovation means that medtech devices related to women’s health are drawing investor ...